SNSE
Sensei Biotherapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Sensei Biotherapeutics (SNSE) Stock: Buy, Sell, or Hold?
$13.85
+0.85 (+6.54%)
â˛
5d:
+6.54%
30d:
-30.12%
90d:
-53.68%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
53/100
Position
FAIR
Forward P/E & Valuation
-1.8x
Next 12M consensus est.
Wall Street Target
$52.50
+279.1% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$12.35 / $21.50
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: SNSE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When SNSE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SNSE is currently trading at $13.85, which is considered fair based on recent price action.
Technical Outlook: Technically, SNSE is in a uptrend. Immediate support is located at $12.35, while resistance sits at $21.50. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: SNSE scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $52.50 (+279.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNSE is in a uptrend. Immediate support is located at $12.35, while resistance sits at $21.50. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: SNSE scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $52.50 (+279.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
53/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
50.0%
Trading Range & Key Levels
Support Level
$12.35
Resistance Level
$21.50
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading 279.1% below Wall St target ($52.50)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.75
Wall Street Target
$52.50
(+279.1%)
Share SNSE Analysis
Share this live SNSE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SNSE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 11, 2026
Daily AI digest
AI Retail Discussion Summary:
A single bullish message on StockTwits suggests strong buyer sentiment for $SNSE.
Key Retail Themes:
Buy recommendations from individual investors
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:43 PM ET
Data refreshes hourly during market hours. Next update: 7:43 PM
Data refreshes hourly during market hours. Next update: 7:43 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNSE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
KURA
Kura Oncology Inc |
STRONG BUY
16 analysts |
$32 | 63 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SNSE Research Pages
